Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes - PubMed (original) (raw)
. 2003 Jul 8;100(14):8384-8.
doi: 10.1073/pnas.0932778100. Epub 2003 Jun 18.
Anne M Evans, Bingye Han, Toshiyuki Takaki, Yuliya Vinnitskaya, Jennifer A Caldwell, David V Serreze, Jeffrey Shabanowitz, Donald F Hunt, Stanley G Nathenson, Pere Santamaria, Teresa P DiLorenzo
Affiliations
- PMID: 12815107
- PMCID: PMC166238
- DOI: 10.1073/pnas.0932778100
Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes
Scott M Lieberman et al. Proc Natl Acad Sci U S A. 2003.
Abstract
Type 1 diabetes is an autoimmune disease in which autoreactive T cells attack and destroy the insulin-producing pancreatic beta cells. CD8+ T cells are essential for this beta cell destruction, yet their specific antigenic targets are largely unknown. Here, we reveal that the autoantigen targeted by a prevalent population of pathogenic CD8+ T cells in nonobese diabetic mice is islet-specific glucose-6-phosphatase catalytic subunit-related protein (IGRP). Through tetramer technology, IGRP-reactive T cells are readily detected in islets and peripheral blood directly ex vivo. The human IGRP gene maps to a diabetes susceptibility locus, suggesting that IGRP also may be an antigen for pathogenic T cells in human type 1 diabetes and, thus, a new, potential target for diagnostic and therapeutic approaches.
Figures
Fig. 1.
Identification of IGRP206–214 as the β cell peptide recognized by the pathogenic T cell clone 8.3. (A–C) Epitope reconstitution activity of first-dimension (A), second-dimension (B), and third-dimension (C) HPLC fractions of H-2Kd-eluted NIT-1 peptides. (D) Determination of candidate peptides by correlation of ion abundance curves (solid lines; plotted on the left and bottom axes) with epitope reconstitution activity of third-dimension HPLC fractions (broken line, ⋄; plotted on the right and top axes). Peptide m/z values are 548.845 (red diamonds), 513.285 (▴), 509.78 (+), 555.805 (-), and 555.835 (▪). (E) Collision-activated dissociation mass spectrum of candidate peptide (M + 2H)+2 ion with monoisotopic m/z of 548.845. X represents I or L. Ions observed in the spectrum are underlined; the b ions originate from the N terminus of the peptide, and the y ions originate from the C terminus. (F) Response of 8.3 CTL toward RMA-S/Kdtarget cells pulsed with varying concentrations of VYLKTNVFL (▴), IYQKAFDLI (▪), NRP-V7 (⋄), or NRP-A7 (+). (G) Response of 8.3 CTL toward COS-7 cells cotransfected (solid lines) with varying concentrations of an IGRP expression construct (▴), or empty vector (▪), together with 10 ng/ml H-2Kd expression construct, or toward separate cultures of COS-7 cells transfected with the H-2Kdconstruct alone and pulsed with varying concentrations of IGRP206–214 peptide (broken line, ⋄). T cell response was measured as IFN-γ release by ELISA and is presented as absorbance at 405 nm (A405).
Fig. 2.
Multiple early insulitic T cell clones recognize IGRP206–214.58α-β-transfectants expressing the indicated TCRs were cultured with RMA-S/Kd cells pulsed with 1.0 (solid bars), 0.1 (open bars), or 0.01 μM (striped bars) of the indicated peptides, and IL-2 release was measured by ELISA. The partial TCRα and TCRβ chain sequences for 8.3 and for the early insulitic T cell clones AI12.B1.3 and AI15.F5 have been reported (3, 10, 13). The AI4, AI12.B1.1, AI12.B1.2, and AI15.A10 lines, all of which express non-Vα17 TCRα chains, did not respond to any of the peptides tested, although they were capable of signaling through the transfected TCR as evidenced by their release of IL-2 in response to plate-bound anti-CD3ε (data not shown). IGRP, IGRP206–214; INS, INS B15–23; FW, framework residues; CDR, complementarity-determining region.
Fig. 3.
IGRP206–214 does not demonstrate poor peptide binding to H-2Kd. RMA-S/Kd cells were pulsed with 1.0 (solid bars), 0.1 (open bars), or 0.01 μM (striped bars) of the indicated peptides, stained with an anti-H-2Kd antibody, and analyzed by flow cytometry. IGRP, IGRP206–214; INS, INS B15–23; MFI, mean fluorescence intensity.
Fig. 4.
IGRP206–214-reactive T cells are readily detected in islets and peripheral blood of NOD mice directly ex vivo. Cells from islets or peripheral blood of 9- or 20-week-old nondiabetic NOD mice were stained with anti-CD8 antibody and the indicated peptide/H-2Kdtetramers. (Left) Representative tetramer staining patterns of samples from 20-week-old mice gated on the CD8+ population. Numbers indicate percentage of tetramer-positive cells within the CD8+population. (Right) The percentage of IGRP (solid bars) or NRP-V7 (open bars) tetramer-positive cells within the CD8+ population for five individual mice per age group. TUM/H-2Kd tetramers stained 0% of cells in each group. IGRP, IGRP206–214.
Comment in
- A pancreatic beta-cell-specific homolog of glucose-6-phosphatase emerges as a major target of cell-mediated autoimmunity in diabetes.
Hutton JC, Eisenbarth GS. Hutton JC, et al. Proc Natl Acad Sci U S A. 2003 Jul 22;100(15):8626-8. doi: 10.1073/pnas.1633447100. Epub 2003 Jul 14. Proc Natl Acad Sci U S A. 2003. PMID: 12861077 Free PMC article. No abstract available.
Similar articles
- Genetic and therapeutic control of diabetogenic CD8+ T cells.
Santamaria P. Santamaria P. Novartis Found Symp. 2008;292:130-6; discussion 136-45, 202-3. doi: 10.1002/9780470697405.ch12. Novartis Found Symp. 2008. PMID: 19209463 - In situ recognition of autoantigen as an essential gatekeeper in autoimmune CD8+ T cell inflammation.
Wang J, Tsai S, Shameli A, Yamanouchi J, Alkemade G, Santamaria P. Wang J, et al. Proc Natl Acad Sci U S A. 2010 May 18;107(20):9317-22. doi: 10.1073/pnas.0913835107. Epub 2010 May 3. Proc Natl Acad Sci U S A. 2010. PMID: 20439719 Free PMC article. - Toxin-coupled MHC class I tetramers can specifically ablate autoreactive CD8+ T cells and delay diabetes in nonobese diabetic mice.
Vincent BG, Young EF, Buntzman AS, Stevens R, Kepler TB, Tisch RM, Frelinger JA, Hess PR. Vincent BG, et al. J Immunol. 2010 Apr 15;184(8):4196-204. doi: 10.4049/jimmunol.0903931. Epub 2010 Mar 10. J Immunol. 2010. PMID: 20220085 Free PMC article. - Early autoimmune destruction of islet grafts is associated with a restricted repertoire of IGRP-specific CD8+ T cells in diabetic nonobese diabetic mice.
Wong CP, Li L, Frelinger JA, Tisch R. Wong CP, et al. J Immunol. 2006 Feb 1;176(3):1637-44. doi: 10.4049/jimmunol.176.3.1637. J Immunol. 2006. PMID: 16424193 - Cellular and molecular pathogenic mechanisms of insulin-dependent diabetes mellitus.
Yoon JW, Jun HS. Yoon JW, et al. Ann N Y Acad Sci. 2001 Apr;928:200-11. doi: 10.1111/j.1749-6632.2001.tb05650.x. Ann N Y Acad Sci. 2001. PMID: 11795511 Review.
Cited by
- Regulatory CD4+ T cells redirected against pathogenic CD8+ T cells protect NOD mice from development of autoimmune diabetes.
Kakabadse D, Chen D, Fishman S, Weinstein-Marom H, Davies J, Wen L, Gross G, Wong FS. Kakabadse D, et al. Front Immunol. 2024 Sep 16;15:1463971. doi: 10.3389/fimmu.2024.1463971. eCollection 2024. Front Immunol. 2024. PMID: 39351219 Free PMC article. - Antigen-specific T cell responses in autoimmune diabetes.
Dwyer AJ, Shaheen ZR, Fife BT. Dwyer AJ, et al. Front Immunol. 2024 Aug 15;15:1440045. doi: 10.3389/fimmu.2024.1440045. eCollection 2024. Front Immunol. 2024. PMID: 39211046 Free PMC article. Review. - Structural and biochemical analysis of highly similar HLA-B allotypes differentially associated with type 1 diabetes.
Sharma R, Amdare NP, Ghosh A, Schloss J, Sidney J, Garforth SJ, Lopez Y, Celikgil A, Sette A, Almo SC, DiLorenzo TP. Sharma R, et al. J Biol Chem. 2024 Sep;300(9):107702. doi: 10.1016/j.jbc.2024.107702. Epub 2024 Aug 22. J Biol Chem. 2024. PMID: 39173948 Free PMC article. - Innovations Toward Immunopeptidomics.
Abelin JG, Cox AL. Abelin JG, et al. Mol Cell Proteomics. 2024 Sep;23(9):100823. doi: 10.1016/j.mcpro.2024.100823. Epub 2024 Jul 31. Mol Cell Proteomics. 2024. PMID: 39095021 Free PMC article. Review. - Decoding the immune dance: Unraveling the interplay between beta cells and type 1 diabetes.
Roy S, Pokharel P, Piganelli JD. Roy S, et al. Mol Metab. 2024 Oct;88:101998. doi: 10.1016/j.molmet.2024.101998. Epub 2024 Jul 26. Mol Metab. 2024. PMID: 39069156 Free PMC article. Review.
References
- Serreze, D. V. & Leiter, E. H. (2001) Curr. Dir. Autoimmun. 4 31-67. - PubMed
- Tisch, R. & McDevitt, H. (1996) Cell 85 291-297. - PubMed
- Palmer, J. P., Asplin, C. M., Clemons, P., Lyen, K., Tatpati, O., Raghu, P. K. & Paquette, T. L. (1983) Science 222 1337-1339. - PubMed
- Baekkeskov, S., Aanstoot, H. J., Christgau, S., Reetz, A., Solimena, M., Cascalho, M., Folli, F., Richter-Olesen, H., De Camilli, P. & Camilli, P. D. (1990) Nature 347 151-156. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials